February 3, 2026

Seoul: SK bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, announced on Tuesday a net loss of 56.4 billion won (US$39 million) for

Seoul: SK bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, announced on Tuesday a net loss of 56.4 billion won (US$39 million) for

Seoul: SK bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, announced on Tuesday a net loss of 56.4 billion won (US$39 million) for

Seoul: South Korea’s biohealth industry is expected to grow nearly 21 percent this year on constant demand for cosmetics and medicines, a local think tank

Seoul: South Korea’s biohealth industry is expected to grow nearly 21 percent this year on constant demand for cosmetics and medicines, a local think tank

Seoul: South Korea’s biohealth industry is expected to grow nearly 21 percent this year on constant demand for cosmetics and medicines, a local think tank

Seoul: South Korea’s biohealth industry is expected to grow nearly 21 percent this year on constant demand for cosmetics and medicines, a local think tank